Sun Pharma Share Price: Sun Pharma shares in focus ahead of Q2 results today
Shares of Sun Pharma will be in focus as the company will announce its results for the July-September 2024 period later today.
Analysts expect the company to report healthy revenue growth during the second quarter, driven by the domestic business with favourable seasonality and growing volumes.
Revenue from operations is likely to jump 10% year-on-year, according to an average estimate of four brokerages. Meanwhile, net profit for the quarter is seen rising up to 25% year-on-year.
Analysts are building in $482 million US sales in 2QFY25, primarily due to higher specialty sales, tad higher gRevlimid sales, as well as continued ramp-up in gPentasa supplies from Mohali.
Gross margins are likely to improve on a sequential basis, while EBITDA…
